Current Neuropharmacology

Article	Citations
Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction	157
Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease	118
Modulating Ferroptosis: A Novel Approach to Promote Neural Repair in Brain Injury	116
Childhood Trauma and Self-harm in Youths with Bipolar Disorders	101
Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats	94
Neurobiological Mechanisms Underlying Hippocampal Dysfunction in Post-Traumatic Stress Disorder	77
Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential	76
Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring	71
Role of Glycerophospholipid Metabolism in Epilepsy	68
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study	67
Gut Microbiota, Plasma Metabolites, and Synucleinopathies: A Mendelian Randomization Study	65
GLP-1 Receptor Agonists in Neuropathic Pain and Neurodegenerative Diseases: Mechanisms, Therapeutic Potentials, and Future Perspectives	65
Early Family Intervention for Youth at Risk for Bipolar Disorder: Psychosocial and Neural Mediators of Outcome	64
Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS	62
Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson’s Disease: An Update Since 2017	62
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder	61
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management	61
Thematic Selection: Stress and Stress-related Disorders Neurobiology & Translational Aspects of Stress-related Disorders (Part 3)	56
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy	55
Meet the Editorial Board Member	55
The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases	53
Myeloid-derived Suppressor Cells and Multiple Sclerosis	50
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase	50
CREB-Mediated Regulation of Microglial Polarization in Central Nervous System Diseases	49
Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis	46

Targeting the Kynurenine Pathway to Improve Mood Disorders	44
Recent Advances in Guillain-Barré Syndrome: Neurological Disorder, Pathophysiology, Diagnosis, Treatment, and Challenges	44
OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by Inhibiting miR-21-3p Expression	43
Brivaracetam in Refractory Epilepsy: Mechanism, Tolerability, and Clinical Positioning	42
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study	40
Rejuvenating Inter-organellar Communication Via Mitophagy in Ageing and Neurodegeneration	39
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics	39
What is the Role of Lithium in Epilepsy?	39
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation	38
Current Insights of Muscone: Source, Quality Control, and Protection Mechanism of Cerebral Ischemic Injury	37
Microglia-Astrocyte Crosstalk in Post-Stroke Neuroinflammation: Mechanisms and Therapeutic Strategies	36
Antiseizure Medications: Advancements, Challenges, and Prospects in Drug Development	35
Role of Traditional Chinese Medicine Formulations in Reducing Neuroinflammation and Oxidative Stress in Alzheimer’s Disease	35
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials	35
Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's	34
Repetitive Transcranial Magnetic Stimulation Alters Brain Communication Networks to Improve the Cognitive Function in Patients with Amnestic Mild Cognitive Impairment - A Clinical Trial	34
Antioxidants, Hormetic Nutrition, and Autism	34
Exploring Mechanistic Insights by Carotenoids in Neuropathic and Inflammatory Pain	33
Meet the Country Editor	33
Unraveling the Role of Perivascular Macrophages in Alzheimer's Disease: Insights from the Crosstalk between Immunometabolism and Ferroptosis	33
Corrigendum to: “Effects of Alcohol on EEG Activity: A Systematic Review Focused on Sex-Related Differences in Youth”	32
The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease	31
Vortioxetine versus SSRI/SNRI with Pregabalin Augmentation in Treatment-Resistant Burning Mouth Syndrome: A Prospective Clinical Trial	31
Fast Declining Prediction in Alzheimer’s Disease from Early Clinical Assessment	31
Early Enteral Feeding Restores Neurofilament Light Chain Serum Levels in Preterm Newborns	30
Meet the Editorial Board Member	30
Daridorexant and Insomnia in Clinical Practice: A Nominal GroupTechnique Consensus Study among Italian Sleep and Insomnia Experts	30
Long-term Efficacy and Safety of Sodium Oxybate in Treating Alcohol Use Disorder: A Systematic Review and Meta-Analysis	29
mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data	29
Is Antipsychotic Drug Use During Pregnancy Associated with Increased Malformation Rates and Worsening of Maternal and Infant Outcomes? A Systematic Review	29
Resveratrol Supplementation Modulates Endothelial Dysfunction in Alzheimer’s Disease (AD): In Vitro Effects on Human Aortic Endothelial Cells Exposed to AD Plasma	29
Role of Perineuronal Nets in Neuronal Plasticity and Repair: Molecular Perspectives on Psychiatric Disorders	28
Calpain-2 Inhibition or Deletion Enhances Levels of the Transcription Factor, MEIS2, and Stimulates Neurogenesis	28
Paraquat and Parkinson’s Disease: The Molecular Crosstalk of Upstream Signal Transduction Pathways Leading to Apoptosis	28
Nicotine Versus Non-Nicotine Constituents in Neurodegenerative Risk: Evidence from Multivariable Mendelian Randomization	28
The Role of the Microbiota-Gut-Brain Axis in Perinatal Depression: Novel Insights for Treatment	27
The Emerging Role of Quercetin in the Treatment of Chronic Pain	27
Diabetes, Alzheimer's Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review	26
Functional and Clinical Relevance of the Crosstalk between the Glymphatic System and the Lymphatic System	26
Decoding Chemobrain: Insights from Multi-omics Approaches	25
New Insights of Early Brain Injury after Subarachnoid Hemorrhage: A Focus on the Caspase Family	25
Esketamine in Treatment-Resistant Depression: Clinical and Translational Perspectives	25
Gut Microbiome in Alzheimer’s Disease: from Mice to Humans	25
Role of Microglia in Psychostimulant Addiction	25
Major Depression in Comorbidity with Substance use Disorders: Patients’ Features and Clinical-Neurobiological Rationale of Antidepressant Treatments	24
Oxytocin Neuropharmacology: From Brain to Sperm	24
In Vitro and In Vivo Evaluation of Kai-Xin-San Polysaccharides: Antioxidant, Anti-Inflammatory, and Anti-Alzheimer's Disease Activities	24
The Role of Induced Pluripotent Stem Cells in the Treatment of Stroke	24
Elucidating the Possible Molecular Targeting Mechanism of Triptolide in Parkinson's Disease Using Single-Cell RNA-Seq Analysis and Network Pharmacology	24
Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders	24

The Role of Epigenetics in the Pathogenesis and Potential Treatment of Attention Deficit Hyperactivity Disorder	24
Neurobiological Insights into Depression: The STAT3 Signaling Pathway as a Therapeutic Target	23
Subjects Affected by Dementia with Lewy Bodies (DLB) and Multiple System Atrophy (MSA) Elevated Brain-Derived Neurotrophic Factor (BDNF) Serum Levels	23
Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer’s Disease: Recent Advances and Therapeutic Implications	23
New Insights on Mechanisms and Therapeutic Targets of Cerebral Edema	23
Hydroxychloroquine Prevents High-altitude Cerebral Edema by Inhibiting Endothelial Claudin-5 Autophagic Degradation	23
Depression and the Glutamate/GABA-Glutamine Cycle	23
High-definition Transcranial Direct Current Stimulation Improves Cognitive Function in Patients with Cerebral Small Vessel Disease: An Open-label Pilot Study Informed by Cross-sectional Analysis	23
Neuroinflammation: The Role of Anthocyanins as Neuroprotectants	23
3-(2,4-Dimethylbenzylidene)-6-chloroindolin-2-one Alleviates Memory Impairment in D-Galactose-induced Alzheimer Like Pathology in a Mouse Model	23
Visualization of Emerging Trends and Hotspots in Immunotherapy for Glioblastoma: A Bibliometric Analysis (2000-2024)	23
Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds	23
Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis	23
Meet the Section Editor	22
Aryl Hydrocarbon Receptor Establishes a Delicate Balance between the Level of the Trace Amine Tryptamine and Monoamine Oxidase Activity in the Brain and Periphery in Health and Conditions such as Neur	22
From Phenomes to Genes: Phenotype-based Strategies in Rodents for Research on the Neurobiological and Genetic Bases of Psychiatric-relevant Traits	22
A Review on Preclinical Models of Ischemic Stroke: Insights Into the Pathomechanisms and New Treatment Strategies	22
Sensory Reinforced Corticostriatal Plasticity	22
Alzheimer's Disease May Benefit from Olive Oil Polyphenols: A Systematic Review on Preclinical Evidence Supporting the Effect of Oleocanthal on Amyloid-β Load	22
The Modulatory Effects of Anesthetics and Analgesics on Neurophysiological Monitoring and Underlying Mechanisms	21
Mitochondrial Regulatory Network: Multi-dimensional Pathological Mechanism of Ischemic Stroke and New Strategies for Targeted Therapy	21
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats	21
The Potential Role of Glutamate Receptors and their Antagonists or Modulators in Migraine Therapy	21
Prospective Investigation of Glutamate Levels and Percentage Gray Matter in the Medial Prefrontal Cortex in Females at Risk for Postpartum Depression	21
The Dual Role of Microglia in Multiple Sclerosis and its Implications for Diagnostics and Repair	21
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial	21
Bibliometric Analysis of Antipsychotic-induced Metabolic Disorder from 2006 to 2021 Based on WoSCC Database	21
Emerging Roles of Microglia in Blood-Brain Barrier Integrity in Aging and Neurodegeneration	21
Neuro-navigated rTMS Targeting Left Angular Gyrus Promotes White-Gray Matter Remodelling to Improve Cognitive Function in Amnestic Mild Cognitive Impairment Patients: Evidence for Early Alzheimer.s In	21
Spatiomolecular Characterization of Dopamine D2 Receptors Cells in the Mouse External Globus Pallidus	20
Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease	20
Mapping Morphological Similarity Network and Neurotransmitter Abnormalities in Cocaine Use Disorder: A Multimodal Neuroimaging Study	20
Current Insights into the Neurotoxicity of Melamine: A Comprehensive Review	20
Bridging Glial Cell Membrane Proteins and Mitochondria for Combating CNS Inflammatory and Neoplastic Diseases	20
Targeting Estrogen Signaling in the Radiation-induced Neurodegeneration: A Possible Role of Phytoestrogens	20
Recent Advances in Blood-brain Barrier (BBB)-Penetrating Nanomaterials for Neurological Disease Imaging, Diagnosis, and Therapy	20
Advances in the Mechanism of ceRNA Regulation in Postoperative Cognitive Dysfunction	19
Association between Suicidal Ideation and Immune Parameters in First-episode Patients with Schizophrenia	19
Neonatal Arterial Ischaemic Stroke: Advances in Pathologic Neural Death, Diagnosis, Treatment, and Prognosis	19
Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective Study	19
Bibliometric Analysis of the Research Status and Global Trends in Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease from 2002 to 2022	19
Machine Learning and Pharmacogenomics at the Time of Precision Psychiatry	18
Rhodiola sacra Protects Against Hippocampal Neuronal Apoptosis in Chronic Cerebral Ischemia via SIRT1-Driven Mitochondrial Biogenesis	18
PP2A: Decoding Its Structure, Regulation and Therapeutic Applications in Neurological Disorders	18
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis	18
Titration of Pharmacological Responses in ICU Patients by Quantified EEG	18
CRISPR in Alzheimer’s Disease: Engineering Genetic Solutions for Neurodegenerative Resilience	18
Micronutrient-Assisted Biomaterial Strategies as Neuropharmacological Modulators of Neuroinflammation and Oxidative Stress in Neurodegenerative Diseases	18
Virtual Screening-Based Drug Development for the Treatment of Nervous System Diseases	18
Baicalin Attenuates Ferroptosis after Subarachnoid Hemorrhage via the PI3K/AKT/GPX4 and NLRP3 Axis	18
Intracranial Drug Delivery Devices: A Promising Approach for Future Epilepsy Treatment?	17
Conventional and Emerging Drug Targeting Sites in Alzheimer’s Disease and the Role of Translational Informatics in its Diagnosis and Management	17
Exploring the Cellular and Molecular Mechanisms Underlying Alzheimer's Disease Utilizing Cerebral Organoids Derived from Patient-specific Induced Pluripotent Stem Cells (iPSCs): A Review with Implicat	17
Cardiac Safety Profile of Ziprasidone: A Real-World Pharmacovigilance Study Using FAERS and Network Toxicology	17
The Potential Influence of Associated Antidepressants on the Pharmacokinetic Profile of Esketamine in Patients Affected by Treatment-resistant Depression	17
Modulation of in vitro Network Activity by Optogenetic Stimulation of Parvalbumin-positive Interneurons During Estrous Cycle	17
Restoring Brain Pathways Involved in Diabetes-Associated Neurocognitive Disorders: The Potential of Dipeptidyl Peptidase 4 Inhibitors as a Therapeutic Strategy	17
Sensorimotor Alterations Induced by Novel Fentanyl Analogs in Mice: Possible Impact on Human Driving Performances	17
Post-Herpetic Neuralgia: Review of Pathophysiology, Mechanisms, and Drug Treatment	17
Probiotics Decrease C-Reactive Protein Levels in Depression Depending on Metabolic Syndrome Presence or Antidepressant Treatment – Secondary Results of a Randomized Clinical Trial	17
UFMylation: A Potential Modification for Neurological Diseases	17
Ocrelizumab Discontinuation vs. Continuation After Safety Events: Comparative Insights from MSBase	17
NMDA Receptor-Targeted Neuroprotection in Ischemic Stroke: The 3S Framework Integrating Spatiotemporal Dynamics, Subtype Selectivity, and Signaling Pathways	17
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions	17
Anti-alzheimer Drugs Development and Small Molecules: Mechanistic Understanding of the 5HT₄ and 5-HT₆ Receptor	17
The Diverse Network of Brain Histamine in Feeding: Dissect its Functions in a Circuit-Specific Way	16
Cariprazine Augmentation in Treatment-Resistant Bipolar Depression: Data from a Retrospective Observational Study	16
Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer’s Disease	16
Resilience and Recalibration of Bibliometric Indicators in Neurosciences and Neuropharmacology Journals After COVID-19: A Longitudinal Rate of Change Analysis Using Mixed-Effects Models	16
Isolated Mitochondrial Preparations andIn organelloAssays: A Powerful and RelevantEx vivoTool for Assessment of Brain (Patho)physiology	16
An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson’s Disease	16
The Dorsolateral Prefrontal Cortex: A High-level Hub for Allostatic Cardiovascular Control	16
Fabry Disease: Current and Novel Therapeutic Strategies. A Narrative Review	16
The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia	16
Intercellular Communication Pathways in Cerebral Ischemia:Mechanisms, Molecular Insights, and Therapeutic Implications	16
Caffeic Acid and Its Derivatives as Potential Therapies for Neurological Disorders	16
A New Augmentation Strategy against Depression Combining SSRIs and the N-terminal Fragment of Galanin (1-15)	16
Brain-targeted Therapies for Irritable Bowel Syndrome: Mechanisms and Strategies	16
Spatial Transcriptomic Dissection of the Cellular and Molecular Architecture of Fear Memory and its Association with Memory Function	15
PCSK9 Inhibitors for Secondary Prevention in Patients with Prior Stroke: A PRISMA-Guided Systematic Review	15

7,8-Dihydroxyflavone and Neuropsychiatric Disorders: A Translational Perspective from the Mechanism to Drug Development	15
Early-Life Microbiome and Neurodevelopmental Disorders: A Systematic Review and Meta-Analysis	15
Secondary White Matter Injury Mediated by Neuroinflammation after Intracerebral Hemorrhage and Promising Therapeutic Strategies of Targeting the NLRP3 Inflammasome	15
Advances on Epigenetic Drugs for Pediatric Brain Tumors	15
Nano-Based Therapeutics in Rare Disease Management: Current Perspectives, Challenges, and Unmet Needs	14
Acknowledgements to Reviewers	14
Does the Brain Matter? Cortical Alterations in Pediatric Bipolar Disorder: A Critical Review of Structural and Functional Magnetic Resonance Studies	14
Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration	14
Therapeutic Approaches Interfering with Nuclear Localization Signals: An Emerging Strategy for CNS-Related Diseases	14
Beneficial and Detrimental Effects of Uric Acid on Alzheimer’s Disease	14
Galectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases	14
A Bibliometric and Visual Analysis of Single Nucleotide Polymorphism Studies in Depression	14
Abusive use of Zolpidem as a Result of COVID-19 and Perspectives of Continuity of the Problem in the Post-Pandemic Period	14
Targeting the Main Sources of Reactive Oxygen Species Production: Possible Therapeutic Implications in Chronic Pain	14
Vasoactive Intestinal Peptide: A Neuropeptide that Plays an ImportantRole in Parkinson's Disease	13
Pathways from the Superior Colliculus to the Basal Ganglia	13
The Fragile Balance: Autophagy's Role in Neurodegenerative Disease Progression	13
Epigenetics of Fear, Anxiety and Stress – Focus on Histone Modifications	13
The MID1IP1/S100A10-mGluR5 Axis in Seizures: Immune-Metabolic Crosstalk and Enhanced Therapeutic Efficacy of Benfotiamine/Phenytoin Combination	13
Determining the Interaction in a Drug Combination using the Dose-based or Effect-based Method	13
Striatal Acetylcholine and Dopamine Interactions Produce Situationappropriate Action Selection	13
Beyond its Psychiatric Use: The Benefits of Low-dose Lithium Supplementation	13
Research Trends and Progress of Microglia in Parkinson’s Disease: A Bibliometric Analysis	13
Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression	12
How to Modulate Peripheral and Central Nervous System to Treat Acute Postoperative Pain and Prevent Pain Persistence	12
Emerging Neurobiological Concepts and Therapies for Neurological Rare Diseases	12
Neural Networks of Knowledge: Ontologies Pioneering Precision Medicine in Neurodegenerative Diseases	12
Powering Up the Brain: Intercellular Mitochondrial Quality Control andIts Implication in Stroke	12
Exploring the Effectiveness and Potential Pharmacological Mechanism of Minocycline for Spinal Cord Injury through Meta-Analysis and Network Pharmacology	12
MicroRNAs as Potential Biomarkers and Therapeutic Targets in Ischemic Stroke from the Perspective of Inflammation	12
Meet the Country Editor	12
Proteome-wide Mendelian Randomization and Colocalization Nominate CD58, PARP1, and Immune Co-stimulatory Pathways as Genetically Supported Targets for Multiple Sclerosis	12
The Natural Protoalkaloid Methyl-2-Amino-3-Methoxybenzoate (MAM) Alleviates Positive as well as Cognitive Symptoms in Rat and Mouse Schizophrenia Models	12
Mediterranean Pattern Diet in Multiple Sclerosis: A Review Focusing on Immunometabolites	12
Central Sensitization and Pain: Pathophysiologic and Clinical Insights	12
A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis	12
Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort	12
Preface	12
Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review	11
Bipolar Disorder and Manic-Like Symptoms in Alzheimer’s, Vascular and Frontotemporal Dementia: A Systematic Review	11
The Role of Non-Pharmacological Interventions in Attenuating Anxiety and Stress Symptoms in PTSD: A Systematic Review	11
Astrocytes in Neurofluid Drainage and Brain Disorders: Mechanisms and Therapeutic Implications	11
Therapeutic Potential of Anesthesiology for Sleep Disorders in the Perioperative Period	11
Epigenetic Mechanisms in the Pathophysiology and Progression of Epilepsy: A Comprehensive Review of Experimental and Clinical Studies	11
Mechanisms and Therapeutic Targeting of the cGAS-STING Pathway in Central Nervous System Disorders	11
Exploring Risk Drugs and Mechanisms in Dystonia: Insights from Pharmacovigilance and Proteogenomics	11
Protein Kinases in Alzheimer’s Disease: Pioneering Insights into Pathogenesis and Therapeutic Breakthroughs	11
The Efficacy of Glucagon‐like Peptide‐1 Receptor Agonists on Different Cognitive Domains: A Meta-analysis of Randomized Controlled Trials	11
Potential Benefits of Quercetin through P2X7 Modulation against Neuroinflammation in Alzheimer's Disease	11
Neutrophil Heterogeneity and its Roles in the Inflammatory Network after Ischemic Stroke	11
Antidepressant Prescription for Major Depressive Disorder: Results from a Population-Based Study in Italy	11
Mechanisms and Applications of Transcranial Ultrasound Stimulation in Neurological Disorders and Psychiatric Conditions	11
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study)	11
Contribution of Drugs to Drowning in Scotland from 1996 to 2020	11
Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder	11
Neurobehavioral Profiles of Six Genetically-based Rat Models of Schizophrenia- related Symptoms	11
Epilepsy and Cognitive Impairment in Childhood and Adolescence: A Mini-Review	11
Clinical Trials of Non-Coding RNAs as Diagnostic and Therapeutic Biomarkers for Central Nervous System Injuries	10
The Link between Gut Microbiome, Amyloid-Beta Deposition, Brain Inflammation, and Alzheimer’s Disease: A Review of Current Literature	10
Anticholinesterases Traits Inbuilt in Buxaceae Plant Extracts against Alzheimer’s Disease	10
The AGE-RAGE-GLO1 Pathway in Glioma: A Systematic Review of Its Role in Tumour Biology and Therapy	10
Effects of Alcohol on EEG Activity: A Systematic Review Focused on Sex-Related Differences in Youth	10
Efficacy and Safety of Fecal Microbiota Transplantation for Patients with Treatment-resistant Schizophrenia: A Double-blind, Randomized Clinical Trial Protocol	10
Peripheral Immune Regulation of Depression: Within Sight but Beyond Reach?	10
A Case-Control Study On Corpus Callosum Volume and Clinical Correlates in Treatment-Resistant and Responsive Schizophrenia Patients: Addressing MRI Analysis within Single-Subject and a Novel Artificia	10
Alternative Splicing in Central Nervous System: Molecular Mechanisms and Pathophysiological Roles	10
An Investigation of the Neurotoxic Mechanisms of Benzo[a]pyrene in Alzheimer's Disease Using an Integrated Approach of Network Toxicology and Machine Learning	10
Cryptotanshinone and Its Metabolite Ameliorate Rewarding Effect of Nitrous Oxide via Nucleus Accumbens D1 Receptor and TrkB Pathway	10
Gabapentinoids for Neuropathic Pain Management: A Systematic Umbrella Review	10
Two Distinct Neuronal Populations in the Rat Parafascicular Nucleus Oppositely Encode the Engagement in Stimulus-driven Reward-seeking	10
From the Gut to the Mind: Elucidating the Microbiome-chronobiology Axis in the Context of Depressive Illness	10
Ginseng for Cognitive Function in Elderly Adults with Mild Cognitive Impairment, Alzheimer’s Disease, or Dementia: A Systematic Review and Meta-Analysis	10
Targeting the mTOR Pathway with Natural Products: A Potential Therapeutic Approach for Autism Spectrum Disorders	10
Olanzapine-Induced Weight Gain and Glycolipid Metabolism Aberrations in First-Episode and Antipsychotic-Naïve Schizophrenia Patients: A Longitudinal Study	10
Rethinking ‘Innovation’ in Psychiatry with Older and Newer Treatments: From Bench to Benchside	10
The Role and Diagnostic Value of Astrocyte-Derived Exosomes in Ischemic Stroke	10
The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease	10